Halozyme Therapeutics, Inc. vs. Prime Medicine, Inc. Common Stock
HALO
Halozyme Therapeutics, Inc.
$110.42 +0.53%
VS PRMEPrime Medicine, Inc. Common Stock
$3.99 +11.45%
Halozyme Therapeutics, Inc. and Prime Medicine, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| HALO | PRME | |
|---|---|---|
| Market Cap | $12.53 billion | $723.69 million |
HALO leads on 1 of 1 size & scale factors.
Dividend
| HALO | PRME | |
|---|---|---|
| Dividend Yield | — | 80.20% |
HALO and PRME split the dividend factors evenly.
Risk & Sentiment
| HALO | PRME | |
|---|---|---|
| Short Interest | 9.79% | 0.00% |
PRME leads on 1 of 1 risk & sentiment factors.
Dig deeper: HALO overview, HALO financials, PRME overview, PRME financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.